{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:01:00Z","timestamp":1780581660344,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52985-8","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:46:10Z","timestamp":1780577170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["White blood cell count to platelet ratio (WBC\/PLT) is associated with adverse lipid parameters and lower antioxidants intake in patients with NAFLD"],"prefix":"10.1038","volume":"16","author":[{"given":"Amr Ali Mohamed Abdelgawwad","family":"El-Sehrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Labib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Mosaad","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansuor A.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abohassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehan A.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif M","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehad Mohsen","family":"ELmazny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Kandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"8","key":"52985_CR1","doi-asserted-by":"publisher","first-page":"e0330504","DOI":"10.1371\/journal.pone.0330504","volume":"20","author":"Y Mao","year":"2025","unstructured":"Mao, Y. et al. Global burden of NAFLD 1990\u20132021 and projections to 2035: results from the global burden of disease study 2021. PLoS One. 20 (8), e0330504 (2025).","journal-title":"PLoS One"},{"issue":"3","key":"52985_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"EASL-EASD-EASO Clinical","year":"2024","unstructured":"EASL-EASD-EASO Clinical. Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81 (3), 492\u2013542 (2024).","journal-title":"J. Hepatol."},{"issue":"12","key":"52985_CR3","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.dld.2010.04.005","volume":"42","author":"Y-J Lee","year":"2010","unstructured":"Lee, Y-J. et al. Relationship between white blood cell count and nonalcoholic fatty liver disease. Dig. Liver Disease. 42 (12), 888\u2013894 (2010).","journal-title":"Dig. Liver Disease"},{"issue":"1","key":"52985_CR4","first-page":"7653689","volume":"2016","author":"GE Chung","year":"2016","unstructured":"Chung, G. E. et al. Associations between white blood cell count and the development of incidental nonalcoholic fatty liver disease. Gastroenterol. Res. Pract. 2016 (1), 7653689 (2016).","journal-title":"Gastroenterol. Res. Pract."},{"key":"52985_CR5","doi-asserted-by":"publisher","first-page":"106766","DOI":"10.1016\/j.prostaglandins.2023.106766","volume":"169","author":"N Malladi","year":"2023","unstructured":"Malladi, N., Alam, M. J., Maulik, S. K. & Banerjee, S. K. The role of platelets in non-alcoholic fatty liver disease: from pathophysiology to therapeutics. Prostaglandins Other Lipid mediat. 169, 106766 (2023).","journal-title":"Prostaglandins Other Lipid mediat."},{"key":"52985_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trsl.2020.11.003","volume":"231","author":"L Miele","year":"2021","unstructured":"Miele, L. et al. Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets. Translational Res. 231, 24\u201338 (2021).","journal-title":"Translational Res."},{"key":"52985_CR7","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2147\/DMSO.S367483","volume":"15","author":"H Yin","year":"2022","unstructured":"Yin, H., Shi, A. & Wu, J. Platelet-activating factor promotes the development of non-alcoholic fatty liver disease. Diabetes Metab. Syndr. Obes. 15, 2003\u20132030 (2022).","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"4","key":"52985_CR8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/biomedicines10040892","volume":"10","author":"Y-L Chao","year":"2022","unstructured":"Chao, Y-L. et al. Hepatic steatosis is associated with high white blood cell and platelet counts. Biomedicines 10 (4), 892 (2022).","journal-title":"Biomedicines"},{"issue":"12","key":"52985_CR9","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1097\/MEG.0000000000000203","volume":"26","author":"E Karagoz","year":"2014","unstructured":"Karagoz, E. et al. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Eur. J. Gastroenterol. Hepatol. 26 (12), 1320\u20131324 (2014).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"12","key":"52985_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1524-6175.2005.04809.x","volume":"7","author":"A Jesri","year":"2005","unstructured":"Jesri, A., Okonofua, E. C. & Egan, B. M. Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J. Clin. Hypertens. 7 (12), 705\u2013711 (2005).","journal-title":"J. Clin. Hypertens."},{"issue":"1","key":"52985_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67 (1), 328\u2013357 (2018).","journal-title":"Hepatology"},{"issue":"3","key":"52985_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/1756283X16638830","volume":"9","author":"S Zelber-Sagi","year":"2016","unstructured":"Zelber-Sagi, S., Godos, J. & Salomone, F. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therapeutic Adv. Gastroenterol. 9 (3), 392\u2013407 (2016).","journal-title":"Therapeutic Adv. Gastroenterol."},{"key":"52985_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3389\/fimmu.2018.01055","volume":"9","author":"Y Alwarawrah","year":"2018","unstructured":"Alwarawrah, Y., Kiernan, K. & MacIver, N. J. Changes in Nutritional Status Impact Immune Cell Metabolism and Function. Front. Immunol. 9, 1055 (2018).","journal-title":"Front. Immunol."},{"issue":"18","key":"52985_CR14","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal, A. J. et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362 (18), 1675\u20131685 (2010).","journal-title":"N. Engl. J. Med."},{"key":"52985_CR15","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.2147\/DDDT.S83144","volume":"9","author":"MS Ellulu","year":"2015","unstructured":"Ellulu, M. S., Rahmat, A., Patimah, I., Khaza\u2019ai, H. & Abed, Y. Effect of vitamin C on inflammation and metabolic markers in hypertensive and\/or diabetic obese adults: a randomized controlled trial. Drug Des. Devel Ther. 9, 3405\u20133412 (2015).","journal-title":"Drug Des. Devel Ther."},{"issue":"7\u20138","key":"52985_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.nut.2014.11.018","volume":"31","author":"K Sato","year":"2015","unstructured":"Sato, K. et al. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Nutrition 31 (7\u20138), 923\u2013930 (2015).","journal-title":"Nutrition"},{"key":"52985_CR17","doi-asserted-by":"publisher","first-page":"175628482097491","DOI":"10.1177\/1756284820974917","volume":"13","author":"M Abdel-Maboud","year":"2020","unstructured":"Abdel-Maboud, M. et al. The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. Therapeutic Adv. Gastroenterol. 13, 1756284820974917 (2020).","journal-title":"Therapeutic Adv. Gastroenterol."},{"key":"52985_CR18","first-page":"251","volume":"24","author":"K Madan","year":"2005","unstructured":"Madan, K. et al. Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease. Indian J. Gastroenterol. 24, 251\u2013255 (2005).","journal-title":"Indian J. Gastroenterol."},{"key":"52985_CR19","first-page":"20","volume":"5","author":"M Babich","year":"2010","unstructured":"Babich, M. Efficacy of vitamin E and vitamin C in the treatment of nonalcoholic steatohepatitis. Prac Gastroenterol. 5, 20\u201327 (2010).","journal-title":"Prac Gastroenterol."},{"issue":"1","key":"52985_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/09537100903391023","volume":"21","author":"H Ozhan","year":"2010","unstructured":"Ozhan, H. et al. Mean platelet volume in patients with non-alcoholic fatty liver disease. Platelets 21 (1), 29\u201332 (2010).","journal-title":"Platelets"},{"key":"52985_CR21","first-page":"8","volume":"2008","author":"W Consultation","year":"2008","unstructured":"Consultation, W. Waist circumference and waist-hip ratio. Report of a WHO Expert Consultation Geneva. World Health Organ. 2008, 8\u201311 (2008).","journal-title":"World Health Organ."},{"issue":"8","key":"52985_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig, C. L. et al. International physical activity questionnaire: 12- country reliability and validity. Med. Sci. Sports Exerc. 35 (8), 1381\u20131395 (2003).","journal-title":"Med. Sci. Sports Exerc."},{"key":"52985_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"F Wt","year":"1972","unstructured":"Wt, F. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499\u2013502 (1972).","journal-title":"Clin. Chem."},{"issue":"1","key":"52985_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12889-023-17511-9","volume":"24","author":"SM Ajabnoor","year":"2024","unstructured":"Ajabnoor, S. M., Jambi, H. & Bahijri, S. Development and validation of a food frequency questionnaire in adult Saudi subjects in Jeddah city. BMC Public. Health. 24 (1), 9 (2024).","journal-title":"BMC Public. Health"},{"issue":"1","key":"52985_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/sim.2331","volume":"25","author":"P Royston","year":"2006","unstructured":"Royston, P., Altman, D. G. & Sauerbrei, W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat. Med. 25 (1), 127\u2013141 (2006).","journal-title":"Stat. Med."},{"issue":"5","key":"52985_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/bjc.1991.441","volume":"64","author":"DG Altman","year":"1991","unstructured":"Altman, D. G. Categorising continuous variables. Br. J. Cancer. 64 (5), 975 (1991).","journal-title":"Br. J. Cancer"},{"key":"52985_CR27","first-page":"678","volume":"5","author":"A Gros","year":"2014","unstructured":"Gros, A., Ollivier, V. & Ho-Tin-No\u00e9, B. Platelets in inflammation: regulation of leukocyte activities and vascular repair. Front. Immunol. 5, 678 (2014).","journal-title":"Front. Immunol."},{"key":"52985_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.64943\/ljmas.v3i3.146","volume":"3","author":"AM Bofares","year":"2025","unstructured":"Bofares, A. M. et al. Assessment of hematological and metabolic marker in relation to NAFLD severity: A gender-based study at Al-Wahda hospital-Derna. Libyan J. Med. Appl. Sci. 3, 95\u201399 (2025).","journal-title":"Libyan J. Med. Appl. Sci."},{"key":"52985_CR29","unstructured":"Feingold, K. R. & Grunfeld, C. The Effect of Inflammation and Infection on Lipids and Lipoproteins (Endotext, 2022)."},{"issue":"7","key":"52985_CR30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit, W. et al. Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J. Lipid Res. 45 (7), 1169\u20131196 (2004).","journal-title":"J. Lipid Res."},{"issue":"1","key":"52985_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","volume":"22","author":"D Kim","year":"2018","unstructured":"Kim, D., Touros, A. & Kim, W. R. Nonalcoholic fatty liver disease and metabolic syndrome. Clin. Liver Dis. 22 (1), 133\u2013140 (2018).","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"52985_CR32","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1038\/s41598-024-56796-7","volume":"14","author":"EK Choe","year":"2024","unstructured":"Choe, E. K. & Kang, H. Y. The association between platelet-related parameters and nonalcoholic fatty liver disease in a metabolically healthy nonobese population. Sci. Rep. 14 (1), 6118 (2024).","journal-title":"Sci. Rep."},{"issue":"7","key":"52985_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11883-022-01028-4","volume":"24","author":"A Martin","year":"2022","unstructured":"Martin, A. et al. Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease. Curr. Atheroscler. Rep. 24 (7), 533\u2013546 (2022).","journal-title":"Curr. Atheroscler. Rep."},{"issue":"1","key":"52985_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/138161211795049804","volume":"17","author":"A Yuri Gasparyan","year":"2011","unstructured":"Yuri Gasparyan, A., Ayvazyan, L., Mikhailidis, P. & Kitas, D. D. Mean platelet volume: a link between thrombosis and inflammation? Curr. Pharm. Design. 17 (1), 47\u201358 (2011).","journal-title":"Curr. Pharm. Design"},{"issue":"4","key":"52985_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5603\/CJ.a2015.0015","volume":"22","author":"MR Dehghani","year":"2015","unstructured":"Dehghani, M. R., Rezaei, Y. & Taghipour-Sani, L. White blood cell count to mean platelet volume ratio as a novel non-invasive marker predicting long-term outcomes in patients with non-ST elevation acute coronary syndrome. Cardiol. J. 22 (4), 437\u2013445 (2015).","journal-title":"Cardiol. J."},{"issue":"9","key":"52985_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1096\/fasebj.13.9.1007","volume":"13","author":"A Carr","year":"1999","unstructured":"Carr, A. & Frei, B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J. 13 (9), 1007\u20131024 (1999).","journal-title":"FASEB J."},{"issue":"10","key":"52985_CR37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1096\/fasebj.13.10.1145","volume":"13","author":"R Brigelius-Floh\u00e9","year":"1999","unstructured":"Brigelius-Floh\u00e9, R. & Traber, M. G. Vitamin E: function and metabolism. FASEB J. 13 (10), 1145\u20131155 (1999).","journal-title":"FASEB J."},{"issue":"1","key":"52985_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0168-8278(02)00073-9","volume":"37","author":"S Seki","year":"2002","unstructured":"Seki, S. et al. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J. Hepatol. 37 (1), 56\u201362 (2002).","journal-title":"J. Hepatol."},{"issue":"29","key":"52985_CR39","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.2174\/1381612811319290004","volume":"19","author":"S Petta","year":"2013","unstructured":"Petta, S., Handberg, A. & Craxi, A. Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease. Curr. Pharm. Design. 19 (29), 5193\u20135218 (2013).","journal-title":"Curr. Pharm. Design"},{"issue":"1","key":"52985_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64 (1), 73\u201384 (2016).","journal-title":"Hepatology"},{"issue":"2","key":"52985_CR41","doi-asserted-by":"publisher","first-page":"e0318847","DOI":"10.1371\/journal.pone.0318847","volume":"20","author":"EH Cho","year":"2025","unstructured":"Cho, E. H. et al. Mean platelet volume as a biomarker for liver fibrosis in patients with Non-alcoholic fatty liver disease. PloS one. 20 (2), e0318847 (2025).","journal-title":"PloS one"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52985-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52985-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52985-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:06:11Z","timestamp":1780578371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52985-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52985"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52985-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Mansoura University (Ethics code: R.26.02.3593). All participants provided written informed consent prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"17362"}}